Jon CohenScience’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.Now there are two.
Another COVID-19 vaccine using the same previously unproven technology as the vaccine from Pfizer and BioNTech, the U.S and German companies that reported success on 9 November, appears to work remarkably well.
And this time the maker, the U.S. biotech Moderna, is releasing a bit more data than the other two companies to back its claim.An independent board monitoring Moderna’s 30,000-person vaccine trial met on Sunday and reported to the company and U.S.